{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "DealBook Online; Irish drug maker Horizon Pharma increases unsolicited offer for Depomed to $33 per share, representing 60 percent premium over closing price.", "type_of_material": "News", "word_count": "672", "lead_paragraph": "Horizon Pharma said it was willing to pay $33 a share for its smaller American rival, up from its previous offer of $29.25 a share.", "pub_date": "2015-07-22T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Drug Maker Depomed Skeptical of Horzon Pharma\u2019s Latest Bid", "print_headline": "Drug Maker Offer"}, "snippet": "Horizon Pharma said it was willing to pay $33 a share for its smaller American rival, up from its previous offer of $29.25 a share.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/07/22/business/dealbook/horizon-pharma-sweetens-bid-for-drug-maker-depomed.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Horizon Pharma Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Depomed Inc", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "55ae38a038f0d84cf5633e5b", "source": "The New York Times"}